Beta Bionics (BBNX) Depreciation & Amortization (CF) (2024 - 2026)

Beta Bionics has disclosed Depreciation & Amortization (CF) across 3 years of filings, most recently posting $600000.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $600000.0, up 98.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 62.55% YoY), and the FY2025 annual result was $1.6 million, up 39.01% from the prior year.
• Depreciation & Amortization (CF) came in at $600000.0 for Q1 2026 at Beta Bionics, roughly flat from $600000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $600000.0 in Q4 2025 to a low of $251000.0 in Q4 2024.
• The 3-year median for Depreciation & Amortization (CF) is $313000.0 (2024), against an average of $372333.3.
• Peak annual rise in Depreciation & Amortization (CF) reached 139.04% in 2025, while the deepest fall reached 5.57% in 2025.
• Beta Bionics' Depreciation & Amortization (CF) stood at $251000.0 in 2024, then jumped by 139.04% to $600000.0 in 2025, then changed by 0.0% to $600000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $600000.0 (Q1 2026), $600000.0 (Q4 2025), and $350000.0 (Q3 2025), per Business Quant data.